DRKS00004778已完成不适用
Prospective study to investigate meropenem serum levels in sepsis patients with and without renal replacement therapy - Mero-REPLACE
niversitätsklinikum Jena - Klinik für Anästhesiologie und Intensivtherapie0 个研究点目标入组 40 人开始时间: 2013年7月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Sepsis, antimicrobial therapy with meropenem as indicated by the treating physician, age =18 years, in 30 patients: treatment with extended daily dialysis (n=15) or treatment with continuous hemodialysis (n=15)
排除标准
- •age <18 years, pregnant or lactating women, meropenem in cerebral infections, participation in another interventional trial, other renal replacement therapy as daily extended dialysis or continuous hemodialysis, dialysis in the last 12 hours before study inclusion, acute kidney failure (creatinine clearance <80 ml/min) without indication for renal replacement therapy, no commitment for full organ support (i.e. DNR order), not expected to survive this hospital stay because of preexisting diseases, staff and their relatives
研究者
相似试验
招募中
4 期
Pilot randomised controlled trial of meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections.Participants who have had a bloodstream infection with a specific gram negative bacteria, as defined by at least one positive blood culture, where the isolate is confirmed to be a likely AmpC-producer by resistance to Ampicillin, Amoxicillin/clavulanate and 1st generation cephalosporins (e.g. cephazolin). The isolate should also remain susceptible to piperacillin/tazobactam and meropenem.Infection - Studies of infection and infectious agentsACTRN12614001211651The University of Queensland Centre for Clinical Research100
已完成
4 期
Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem TreatmentCentral Nervous System InfectionsNCT02506686Huashan Hospital82
招募中
不适用
Therapeutic drug monitoring of Meropenem, Linezolide and Tigecyclin in liver failure. Quantification of liver function with Maximal Liver Function Capacity test (LiMAx-Test).K72.0Acute and subacute hepatic failureDRKS00008888Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum. Klinik für Allgemein-, Visceral, und Transplantationschirurgie420
已完成
4 期
Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care UnitsInitial Phase of Severe Sepsis and Septic ShockNCT02213796Sutep Jaruratanasirikul9
进行中（未招募）
1 期
Measurement of antabiotic concentration i subcutis and blood in patients receiving ECMO treatmentInfections related to ECMO-hospitalisationMedDRA version: 17.1Level: PTClassification code 10022519Term: Intensive careSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2015-000218-23-DKAarhus University Hospital, Skejby